ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 824 filers reported holding ISHARES TR in Q3 2022. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $13,519 | +0.9% | 110 | 0.0% | 0.01% | 0.0% |
| Q3 2023 | $13,396 | -4.1% | 110 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $13,973 | -2.7% | 110 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $14,356 | +0.9% | 110 | 0.0% | 0.01% | -10.0% |
| Q4 2022 | $14,234 | +9.5% | 110 | 0.0% | 0.01% | +11.1% |
| Q3 2022 | $13,000 | +62.5% | 110 | +57.1% | 0.01% | +50.0% |
| Q2 2022 | $8,000 | -11.1% | 70 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $9,000 | -10.0% | 70 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $10,000 | -16.7% | 70 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $12,000 | +9.1% | 70 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $11,000 | 0.0% | 70 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $11,000 | 0.0% | 70 | 0.0% | 0.01% | -18.2% |
| Q4 2020 | $11,000 | +22.2% | 70 | 0.0% | 0.01% | +10.0% |
| Q3 2020 | $9,000 | -10.0% | 70 | 0.0% | 0.01% | -9.1% |
| Q2 2020 | $10,000 | 0.0% | 70 | -22.2% | 0.01% | -8.3% |
| Q1 2020 | $10,000 | – | 90 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |